Extracts
Standardised cannabis extracts produced under recorded parameters, used as the input for finished formats or supplied as bulk to licensed partners.
Products
We manufacture cannabis based medicines in four formats for regulated medical markets. We publish no prices, no consumer claims and no sales channel.

Platform
Every format begins with EU-GACP certified flower from Hybrida Farms and ends with a tested, documented batch.
Standardised cannabis extracts produced under recorded parameters, used as the input for finished formats or supplied as bulk to licensed partners.
Oil formulations prepared to a defined cannabinoid specification, filled and labelled in the licensed facility.
Liquid oral formats developed for markets and prescribers that require an alternative to oil presentations.
Solid oral dose formats manufactured to a written specification with batch reconciliation and testing.

Intended markets
Our first export destinations are Germany, Switzerland and the United Kingdom. Products are developed for regulated medical markets and supplied only to licensed counterparties.
First export destinations. Availability in any market depends on the importing country's regulatory requirements and the licences held by our counterparties.
We intend to serve Costa Rican patients as soon as the national regulatory framework permits.
What partners receive
This page is intended for licensed counterparties, regulators and healthcare professionals. It is not a product offer, it contains no prices and it makes no therapeutic claims.
Licensed importers, distributors and research organisations can request our licence details, specifications and testing scope. Select Licensed importer or distributor on the contact form.
Request the compliance pack